MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications
Open Access
- 1 October 2020
- journal article
- review article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 13, 10851-10866
Abstract
Colorectal cancer (CRC) is the third-commonest malignant cancer, and its metastasis is the major reason for cancer-related death. The process of metastasis is highly coordinated and involves a complex cascade of multiple steps. In recent years, miRNAs, as highly conserved, endogenous, noncoding, single-stranded RNA, has been confirmed to be involved in the development of various cancers. Considering that miRNA is also involved in a series of biological behaviors, regulating CRC occurrence and development, we review and summarize the role of miRNAs and related signaling pathways in several CRC-metastasis stages, including invasion and migration, mobility, metabolism, epithelial–mesenchymal transition, tumor-microenvironment communication, angiogenesis, anoikis, premetastatic–niche formation, and cancer stemness. In addition, we review the application of miRNAs as diagnostic CRC markers and in clinical treatment resistance. This review can contribute to understanding of the mechanism of miRNAs in CRC progression and provide a theoretical basis for clinical CRC treatment.Keywords
This publication has 155 references indexed in Scilit:
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasisGut, 2012
- MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF R2) in colon cancer cellsCarcinogenesis, 2011
- microRNAs: Master Regulators as Potential Therapeutics in CancerAnnual Review of Pharmacology and Toxicology, 2011
- P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesisProceedings of the National Academy of Sciences, 2010
- Anoikis resistance and tumor metastasisCancer Letters, 2008
- The impact of microRNAs on protein outputNature, 2008
- MicroRNAs accurately identify cancer tissue originNature Biotechnology, 2008
- MicroRNA expression profiles classify human cancersNature, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2European Journal of Immunology, 2002